Product logo
  • Home
  • Sign Up
Product logo

Bal Pharma Ltd

News

Switch to
More ontickertape logoapp
    Home
    Sign Up

    Bal Pharma Ltd

    BALPHARMA
    67.052.60 (+4.03%)
    Scorecard

    Performance

    Low

    Hasn't faired well - amongst the low performers

    Valuation

    High

    Seems to be overvalued vs the market average

    Growth

    Avg

    Financials growth has been moderate for a few years

    Profitability

    High

    Showing good signs of profitability & efficiency

    Entry point

    Good

    The stock is underpriced and is not in the overbought zone

    Red flags

    Low

    No red flag found

    Get your Zerodha accountOpen Now

    Go Pro! to unlock score, rank

    and other metrics

    How to use scorecard? Learn more

    OverviewForecastsFinancialsPeersHoldingsNewsEvents
    700

    News & Opinions

    700
    Articles & Videos
    News Thumbnail

    Bal Pharma Consolidated December 2022 Net Sales at Rs 76.62 crore, up 10.77% Y-o-Y

    1 month ago•Moneycontrol

    News Thumbnail

    Balkrishna Paper Mills Ltd leads gainers in ‘B’ group

    3 months ago•Business Standard

    News Thumbnail

    Yaari Digital Integrated Services Ltd leads gainers in ‘B’ group

    1 year ago•Business Standard

    News Thumbnail

    Intense Technologies Ltd leads gainers in ‘B’ group

    1 year ago•Business Standard

    News Thumbnail

    MSP Steel & Power Ltd leads losers in ‘B’ group

    1 year ago•Business Standard

    News Thumbnail

    Shree Rama Multi-Tech Ltd leads gainers in ‘B’ group

    1 year ago•Business Standard

    News Thumbnail

    ICRA upgrades credit rating outlook of Bal Pharma from Stable to Positive; Stock soars 3%

    1 year ago•India Infoline

    © Powered byTickertape.ViewBALPHARMAon 

    EmailHelpBlog

    NSE & BSE – SEBI Registration No: INZ000031633 | CDSL - SEBI  Registration No: IN-DP-431-2019

    Zerodha - NSE & BSE – SEBI Reg. No.: INZ000031633
    Zerodha - CDSL - SEBI Reg. No: IN-DP-431-2019